MCM
PGNX

Matarin Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Matarin Capital Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-25,228
Closed -$238K – 311
2017
Q1 		$238K Buy
+25,228
New +$238K 0.02% 262